SCNX

2.2786.45%
NM

Narasimhan Mani

President, Co-CEO, Interim CFO & Director

Dr. Narasimhan Mani, M.B.A., Ph.D. is President, Co-CEO & Director of Scienture Holdings, Inc. since May 2025 and has been its Interim CFO from May 26, 2026. Dr. Mani was President of Scienture LLC of Scienture Holdings, Inc. from August 2024. Dr. Mani was Director of Scienture Holdings, Inc. from July 25, 2024 to January 15, 2025. He was Director of TRxADE HEALTH, Inc. from May 28, 2024 to June 2024. Dr. Mani is an experienced healthcare professional with years of experience in the pharmaceutical industry. Prior to Scienture, he most recently served as the President and Chief Executive Officer for Kesin Pharma Corporation, a specialty pharma company with a focus on commercializing specialty and brand products. His past roles include serving as the Chief Executive Officer of Xiromed LLC, a generics and specialty drug product company and as the Vice President, Global Corporate Strategy and Business Development, at Amneal Pharmaceuticals where he led all the company’s strategic initiatives across Global Strategy, Portfolio Management, Business Development and Commercial Operations. His previous experiences also include being the Corporate Finance and Strategic Planning Leader at Johnson & Johnson in New Brunswick, New Jersey, in the pharmaceutical and medical device sectors. He also worked as a Research Scientist and Product Development leader during his time at Forest Laboratories and Par Pharmaceuticals. He is an invited member of the Executives-in-Residence at New Rhein Healthcare Investors, a life-sciences focused private equity firm and serves on the board of directors at Corsair Pharma, Inc., one of their portfolio companies. Dr. Mani’s journey in the pharmaceutical and healthcare space began with his B.Pharm (Hons.) from BITS, Pilani, India which he completed in 1995. His subsequent graduate degrees include M.S. Analytical Chemistry, from the University of Oklahoma, Norman in 1998, Ph.D. in Pharmaceutics, from the University of Georgia, Athens in 2003 and MBA in Finance and Marketing, from Columbia Business School, New York, NY in 2008. Dr. Mani is also the recipient of the 2021 Outstanding 50 Asian Americans in Business Award in September 2021.

公司职务